-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 26, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on February 3, 2020, Pisgah Laboratories, Inc., 3222 Old Hendersonville Highway, Pisgah Forest, North Carolina 28768 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:
Controlled substance Drug code Schedule Difenoxin 9168 I Diphenoxylate 9170 II Levorphanol 9220 II Meperidine intermediate-B 9233 II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.
Start SignatureDated: March 12, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-06168 Filed 3-23-20; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 03/24/2020
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2020-06168
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 26, 2020.
- Pages:
- 16654-16654 (1 pages)
- Docket Numbers:
- Docket No. DEA-607
- PDF File:
- 2020-06168.pdf